Sietske A. Riemersma

1.5k total citations
22 papers, 1.1k citations indexed

About

Sietske A. Riemersma is a scholar working on Pathology and Forensic Medicine, Oncology and Cancer Research. According to data from OpenAlex, Sietske A. Riemersma has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 8 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Sietske A. Riemersma's work include Lymphoma Diagnosis and Treatment (6 papers), Immune Cell Function and Interaction (5 papers) and Breast Cancer Treatment Studies (5 papers). Sietske A. Riemersma is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Immune Cell Function and Interaction (5 papers) and Breast Cancer Treatment Studies (5 papers). Sietske A. Riemersma collaborates with scholars based in Netherlands, United States and United Kingdom. Sietske A. Riemersma's co-authors include Ed Schuuring, Philip M. Kluin, Ekaterina S. Jordanova, Katja Philippo, Claire Newland, John Newsom–Davis, Leendert H. J. Looijenga, Roelandt F.J. Schop, Jos W. R. Meijer and Cornelis J.A. Punt and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Sietske A. Riemersma

22 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sietske A. Riemersma Netherlands	16	470	461	288	228	202	22	1.1k
Soo Jeong Nam South Korea	21	795 1.7×	485 1.1×	150 0.5×	289 1.3×	475 2.4×	49	1.5k
P. A. Hall United Kingdom	14	336 0.7×	466 1.0×	151 0.5×	65 0.3×	162 0.8×	22	865
Pellegrino Crafa Italy	21	686 1.5×	114 0.2×	126 0.4×	146 0.6×	100 0.5×	70	1.2k
Hideyuki Abe Japan	20	416 0.9×	141 0.3×	81 0.3×	213 0.9×	80 0.4×	63	907
P A Bunn United States	14	1.1k 2.3×	295 0.6×	134 0.5×	159 0.7×	295 1.5×	21	1.7k
Amir Behdad United States	22	543 1.2×	303 0.7×	91 0.3×	451 2.0×	141 0.7×	93	1.3k
JP Marolleau France	13	455 1.0×	362 0.8×	42 0.1×	174 0.8×	225 1.1×	29	933
Amy S. Duffield United States	22	343 0.7×	261 0.6×	86 0.3×	86 0.4×	234 1.2×	86	1.5k
Diane L. Pickering United States	16	455 1.0×	490 1.1×	123 0.4×	78 0.3×	82 0.4×	29	1.3k
Irina Bonzheim Germany	26	948 2.0×	1.1k 2.4×	303 1.1×	205 0.9×	427 2.1×	87	1.9k

Countries citing papers authored by Sietske A. Riemersma

Since Specialization

Citations

This map shows the geographic impact of Sietske A. Riemersma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sietske A. Riemersma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sietske A. Riemersma more than expected).

Fields of papers citing papers by Sietske A. Riemersma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sietske A. Riemersma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sietske A. Riemersma. The network helps show where Sietske A. Riemersma may publish in the future.

Co-authorship network of co-authors of Sietske A. Riemersma

This figure shows the co-authorship network connecting the top 25 collaborators of Sietske A. Riemersma. A scholar is included among the top collaborators of Sietske A. Riemersma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sietske A. Riemersma. Sietske A. Riemersma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Knijn, Nikki, Carlijn van de Water, Shannon van Vliet, et al.. (2019). Sequencing of RAS/RAF pathway genes in primary colorectal cancer and matched liver and lung metastases. SHILAP Revista de lepidopterología. 39(1). 2 indexed citations

2.

Jobsen, Jan J., Job van der Palen, Sietske A. Riemersma, et al.. (2018). Breast-conserving therapy in older patients with breast cancer over three decades: progress or stagnation. Journal of Geriatric Oncology. 10(2). 330–336. 2 indexed citations

3.

Wekken, Anthonie J. van der, M F Mastik, Lizza Hendriks, et al.. (2017). Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non–Small Cell Lung Cancer. Clinical Cancer Research. 23(15). 4251–4258. 51 indexed citations

4.

Dekker, Tim, Gerrit K. Hooijer, Sybren L. Meijer, et al.. (2015). Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach. Breast Cancer Research and Treatment. 152(2). 247–252. 16 indexed citations

5.

Jobsen, Jan J., Job van der Palen, F. Ong, Sietske A. Riemersma, & H. Struikmans. (2015). Bilateral breast cancer, synchronous and metachronous; differences and outcome. Breast Cancer Research and Treatment. 153(2). 277–283. 59 indexed citations

6.

Jobsen, Jan J., et al.. (2014). Pattern of Ipsilateral Breast Tumor Recurrence After Breast-Conserving Therapy. International Journal of Radiation Oncology*Biology*Physics. 89(5). 1006–1014. 24 indexed citations

7.

Knijn, Nikki, Leonie J. Mekenkamp, M. Elisa Vink-Börger, et al.. (2011). KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients. British Journal of Cancer. 104(6). 1020–1026. 235 indexed citations

8.

Aa, Maaike A. van der, Th.J.M. Helmerhorst, Sabine Siesling, Sietske A. Riemersma, & J.W.W. Coebergh. (2010). Vaginal and (Uncommon) Cervical Cancers in the Netherlands, 1989–2003. International Journal of Gynecological Cancer. 20(4). 638–645. 9 indexed citations

9.

Jobsen, Jan J., et al.. (2009). The impact of margin status in breast-conserving therapy for lobular carcinoma is age related. European Journal of Surgical Oncology. 36(2). 176–181. 8 indexed citations

10.

Booman, Marije, Annuska M. Glas, Sietske A. Riemersma, et al.. (2006). Mechanisms and Effects of Loss of Human Leukocyte Antigen Class II Expression in Immune-Privileged Site-Associated B-Cell Lymphoma. Clinical Cancer Research. 12(9). 2698–2705. 53 indexed citations

11.

Riemersma, Sietske A., Joost J. Oudejans, Enno Dreef, et al.. (2005). High numbers of tumour‐infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis. The Journal of Pathology. 206(3). 328–336. 48 indexed citations

12.

Corver, Willem E., Ekaterina S. Jordanova, Mathie P.G. Leers, et al.. (2003). Flow Cytometric Sorting of Paraffin-Embedded Tumor Tissues Considerably Improves Molecular Genetic Analysis. American Journal of Clinical Pathology. 120(3). 327–334. 4 indexed citations

13.

Jordanova, Ekaterina S., Sietske A. Riemersma, Katja Philippo, Ed Schuuring, & Philip M. Kluin. (2002). β₂‐microglobulin aberrations in diffuse large B‐cell lymphoma of the testis and the central nervous system. International Journal of Cancer. 103(3). 393–398. 30 indexed citations

14.

Jordanova, Ekaterina S., et al.. (2002). Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B‐cell lymphomas of the testis and the central nervous system. Genes Chromosomes and Cancer. 35(1). 38–48. 57 indexed citations

15.

Riemersma, Sietske A., Ekaterina S. Jordanova, Roelandt F.J. Schop, et al.. (2000). Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites. Blood. 96(10). 3569–3577. 151 indexed citations

16.

Riemersma, Sietske A., Ekaterina S. Jordanova, Roelandt F.J. Schop, et al.. (2000). Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites. Blood. 96(10). 3569–3577. 15 indexed citations

17.

Vincent, Angela, Leslie Jacobson, Agata Polizzi, et al.. (1998). Antibodies Affecting Ion Channel Function in Acquired Neuromyotonia, in Seropositive and Seronegative Myasthenia Gravis, and in Antibody‐mediated Arthrogryposis Multiplex Congenita. Annals of the New York Academy of Sciences. 841(1). 482–496. 31 indexed citations

18.

Verschuuren, Jan J.G.M., et al.. (1997). Age-related susceptibility to experimental autoimmune myasthenia gravis: Immunological and electrophysiological aspects. Muscle & Nerve. 20(9). 1091–1101. 18 indexed citations

19.

Riemersma, Sietske A., Angela Vincent, David Beeson, et al.. (1996). Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function.. Journal of Clinical Investigation. 98(10). 2358–2363. 112 indexed citations

20.

Vincent, Angela, Claire Newland, David Beeson, et al.. (1995). Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. The Lancet. 346(8966). 24–25. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact